In last trading session, Chromadex Corp (NASDAQ:CDXC) saw 1.9 million shares changing hands with its beta currently measuring 1.86. Company’s recent per share price level of $6.99 trading at $0.88 or 14.40% at ring of the bell on the day assigns it a market valuation of $533.92M. That closing price of CDXC’s stock is at a premium of 8.73% from its 52-week high price of $6.38 and is indicating a premium of 81.12% from its 52-week low price of $1.32. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 4.58 million shares which gives us an average trading volume of 929.65K if we extend that period to 3-months.
For Chromadex Corp (CDXC), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 1 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 1 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Chromadex Corp (NASDAQ:CDXC) trade information
Upright in the green during last session for gaining 14.40%, in the last five days CDXC remained trading in the green while hitting it’s week-highest on Wednesday, 11/06/24 when the stock touched $6.99 price level, adding 1.27% to its value on the day. Chromadex Corp’s shares saw a change of 388.81% in year-to-date performance and have moved 95.25% in past 5-day. Chromadex Corp (NASDAQ:CDXC) showed a performance of 113.76% in past 30-days. Number of shares sold short was 2.96 million shares which calculate 10.17 days to cover the short interests.
Chromadex Corp (CDXC) estimates and forecasts
Statistics highlight that Chromadex Corp is scoring comparatively higher than the scores of other players of the relevant industry. The company added 82.51% of value to its shares in past 6 months, showing an annual growth rate of 128.57% while that of industry is 17.00. Apart from that, the company came raising its revenue forecast for fiscal year 2024.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 35.83% during past 5 years.
Chromadex Corp (NASDAQ:CDXC)’s Major holders
Insiders are in possession of 35.39% of company’s total shares while institution are holding 22.56 percent of that, with stock having share float percentage of 34.92%. Investors also watch the number of corporate investors in a company very closely, which is 22.56% institutions for Chromadex Corp that are currently holding shares of the company. VANGUARD GROUP INC is the top institutional holder at CDXC for having 3.39 million shares of worth $9.24 million. And as of 2024-06-30, it was holding 4.5014 of the company’s outstanding shares.
The second largest institutional holder is BLACKROCK INC., which was holding about 3.12 million shares on 2024-06-30. The number of shares represents firm’s hold over 4.1422 of outstanding shares, having a total worth of $8.51 million.
